0
 
       
     
       

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Antihypertensives
Antiretroviral
Antituberculosis
Antibacterials
Immunosuppressant
   

The company has initiated and in process to start of production facilities as per PIC/S guidelines for oral and injectables dosage along with Lyophilization in the therapeutic segment of Oncology.

The company has developed certain new formulations under the segment of Antiretrovirals and Immunosuppressants.

The plant of the company and its associates are undergoing inspection for approval of PIC/S certification.

 
 
 
No Name No Name
   1 Antiretroviral   11 Antifungal
   2 Anti-TB   12 Antihelmintics
   3 Immunosuppressant   13 Antihistamines & Antitussive
   4 Antihypertensives / Cardiovascular   14 Antiemetics
   5 Antdiabetic   15 Antipsychotics
   6 Anticancer   16 Anti-inflammatory / Anti-rheumatic
   7 Antibacterials   17 Antispasmodics
   8 Antiulcerant   18 Corticosteroid
   9 Antiallergics   19 Haemostatics
  10 Antidepressant   20

Dietary supplement/
Nutritional Supplement
 
Anticancer
 
Anastrazole
Strength: 1 mgTablets
Dosage: Tablets
Indication: For adjuvant treatment of hormone receptor positive breast cancer also been used to treat pubertal gynecomastia and McCune-Albright syndrome.
 
Bicalutamide USP
Strength: 50 mg,150mg
Dosage: Tablets
Indication: For treatment (together with surgery or LHRH analogue) of advanced prostatic cancer.
 
Bleomycin USP
Strength: 15 units Dry Powder Injection (Lyophilized)
Dosage: Injection
Indication:For the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents.
 
Bortezomib
Strength: 3.5 mg Dry Powder Injection (Lyophilized)
Dosage: Injection
Indication: For treatment of multiple myeloma in patients who have not been successfully treated with at least two previous therapies.
 
Carboplatin BP
Strength: 450mg/45 ml
Dosage: Injection
Indication:Carboplatin is used to treat various types of cancer. It is a chemotherapy drug that contains platinum. It is used alone or in combination with other medications to slow or stop cancer cell growth.
 
Docetaxel
Strength: 20 mg/0.5ml,80 mg/2ml
Dosage: Liquid Injection
Indication: For the treatment of patients with locally advanced or metastatic breast cancer, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer.
 
Doxorubicin USP
Strength: 50 mg Dry Powder Injection (Lyophilized)
Dosage: Injection
Indication:For the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen
 
Etoposide USP
Strength: 100 mg/5ml
Dosage: Liquid Injection
Indication:For use in the treatment of refractory testicular tumors and as first line treatment in patients with small cell lung cancer. Also used to treat other malignancies such as lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme.
 
Finasteride 5 Mg Usp
Strength: 5 Mg
Dosage: Tablets
Indication: For the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate, Also used for male pattern alopecia, hereditary alopecia, common male baldness.
 
Fuldarabine Phosphate USP
Strength: 50 mg Dry Powder Injection (Lyophilized)
Dosage: Injection
Indication: For the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen
 
Gemcitabine USP
Strength: 200 mg Dry Powder Injection (Lyophilized)
Dosage: Injection
Indication: For the first-line treatment of patients with metastatic breast cancer, cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas..
 
Gemcitabine USP
Strength: 1000 mg Dry Powder Injection (Lyophilized)
Dosage: Injection
Indication: For the first-line treatment of patients with metastatic breast cancer, cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas
 
Imatinib
Strength: 50 mg,100 mg
Dosage: Capsule
Indication: For the treatment Philadelphia chromosome positive chronic myeloid leukemia (CML) and malignant gastrointestinal stromal tumors (GIST).
 
Letrozole USP
Strength: 2.5 mg
Dosage: Tablets
Indication: For treatment of early breast cancer in postmenopausal women who have received adjuvant tamoxifen therapy, metastatic breast cancer, advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
 
Oxaliplatin
Strength: 50 mg Dry Powder Injection (Lyophilized)
Dosage: Injection
Indication: Used in combination with infusional 5-FU/LV, for the treatment of advanced carcinoma of the colon or rectum.
 
Oxaliplatin.
Strength: 100 mg Dry Powder Injection (Lyophilized)
Dosage: Injection
Indication: Used in combination with infusional 5-FU/LV, for the treatment of advanced carcinoma of the colon or rectum.
 
Paclitaxel USP
Strength: 30 mg/ 5ml,100 mg/16.7,260 mg/43.4 ml,300 mg/ 50ml Liquid Injection
Dosage: Liquid Injection
Indication:Used in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast.
 
Zoledronic Acid USP
Strength: 400 mg Dry Powder Injection (Lyophilized)
Dosage: Injection
Indication: For the treatment of hypercalcemia of malignancy, multiple myeloma ,bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. The drug was approved for treatment of Paget's Disease.
 
Everolimus Tablets
Strength: 0.25 mg, 0.50 mg , 0.75 mg & 1.0 mg
Dosage: Tablets
 
 
© 2009 Lok Beta Pvt. Ltd. All rights reserved.
Sitemap   |   Privacy Policy   |   Credits